BDBM346258 N-(5-pyrazin-2-yl-2-pyridyl)-2-[4-[2-(trifluoromethyl)-4-pyridyl]pyrrolo[2,3-d]pyrimidin-7-yl]acetamide::US10202375, Example 21
SMILES: FC(F)(F)c1cc(ccn1)-c1ncnc2n(CC(=O)Nc3ccc(cn3)-c3cnccn3)ccc12
InChI Key: InChIKey=OFVZKOSLNUNKOX-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protein Wnt-3a (Mus musculus) | BDBM346258 (N-(5-pyrazin-2-yl-2-pyridyl)-2-[4-[2-(trifluoromet...) | PDB Reactome pathway KEGG UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Redx Pharma PLC US Patent | Assay Description Mouse L cells transfected to constitutively produce biologically active murine Wnt-3a, referred to as L-Wnt cells, were purchased from the American T... | US Patent US10202375 (2019) BindingDB Entry DOI: 10.7270/Q29W0HMN | |||||||||||
More data for this Ligand-Target Pair |